A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19

BACKGROUND: Current available therapeutic options for Coronavirus Disease-2019 (COVID-19) are primarily focused on treating hospitalized patients, and there is a lack of oral therapeutic options to treat mild to moderate outpatient COVID-19 and prevent clinical progression. Raloxifene was found as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicastri, Emanuele, Marinangeli, Franco, Pivetta, Emanuele, Torri, Elena, Reggiani, Francesco, Fiorentino, Giuseppe, Scorzolini, Laura, Vettori, Serena, Marsiglia, Carolina, Gavioli, Elizabeth Marie, Beccari, Andrea R., Terpolilli, Giuseppe, De Pizzol, Maria, Goisis, Giovanni, Mantelli, Flavio, Vaia, Francesco, Allegretti, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098200/
https://www.ncbi.nlm.nih.gov/pubmed/35582123
http://dx.doi.org/10.1016/j.eclinm.2022.101450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098200/
https://www.ncbi.nlm.nih.gov/pubmed/35582123
http://dx.doi.org/10.1016/j.eclinm.2022.101450

Ejemplares similares